Meet the 2017 Laureates: Eva L. Feldman, MD, PhD

Neurology, June Wilson

Gerald D. Aurbach Award for Outstanding Translational Research

Eva L. Feldman, MD, PhD

Dr. Eva Feldman, MD, PhD, is an exceptional clinician-scientist who has devoted her career towards understanding diabetic neuropathy (DN), improving treatment options for her patients, and educating healthcare professionals on DN diagnosis and treatment.

With over 25 years of continuous NIH funding, her reputation is internationally recognized and she is an opinion leader in neurology. As a young neurologist, she developed a simple screening tool to diagnose DN, the Michigan Neuropathy Screening Instrument (MNSI). The initial paper describing this tool has been cited over 430 times, and the MNSI is now used worldwide and she oversees its use in multiple clinical trials (e.g. SEARCH, CACTI).

In the laboratory, her pioneering studies on neuropathy pathogenesis in metabolic diseases using cell-based models, novel mouse models, and human subjects has identified dyslipidemia during diabetes as a key driver of nervous system damage, leading to new clinical guidelines on patient care, and she serves as the principal investigator on grants aimed at completing comprehensive transcriptomic, proteomic, and metabolomic phenotyping of DN subjects to understand and drive the development of novel therapies.

Her work is reflected in over 350 manuscripts, 69 book chapters, and four books, and her numerous accolades include membership in the National Academy of Medicine and in 2016, Dr. Feldman received the National Physician of the Year for Clinical Excellence award from Castle Connolly in New York.  She also directs the A. Alfred Taubman Medical Research Institute at the University of Michigan, is a past president of the American Neurological Association, and has mentored nine graduate students and over 100 research and clinical fellows throughout her career.

In summary, Dr. Feldman’s exceptional clinical knowledge of DN, coupled with her passion for understanding its clinical course, identifying and treating affected patients, and educating colleagues on DN has transformed the DN landscape. She is an excellent example of the caliber of individual this award represents and is truly deserving of this award.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in